Why must Olympic athletes prove that they have asthma to be permitted to take inhaled β2-agonists?

被引:9
|
作者
Weiler, JM [1 ]
机构
[1] Univ Iowa, Iowa City, IA 52242 USA
关键词
D O I
10.1067/mai.2003.113
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:36 / 37
页数:2
相关论文
共 50 条
  • [41] Tiotropium added to inhaled corticosteroids and long-acting β2-agonists reduces episodes of asthma worsening, irrespective of selected patient baseline characteristics
    Kerstjens, H. A. M.
    Engel, M.
    Moroni-Zentgraf, P.
    Schmidt, H.
    Bateman, E.
    ALLERGY, 2013, 68 : 41 - 41
  • [42] Therapeutic preferences and factors determining the use of inhaled corticosteroids with long-acting β2-agonists in patients with asthma and chronic obstructive pulmonary disease
    Olszanecka-Glinianowicz, Magdalena
    Chudek, Jerzy
    Almgren-Rachtan, Agnieszka
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2021, 38 (05): : 752 - 760
  • [43] Once-Daily Tiotropium Reduces Risk of Exacerbations and Asthma Worsening in Patients With Symptomatic Asthma Despite Treatment With Inhaled Corticosteroids and Long-Acting β2-Agonists
    Tashkin, Donald P.
    Moroni-Zentgraf, Petra
    Engel, Michael
    Schmidt, Hendrik
    Kerstjens, Huib A. M.
    CHEST, 2013, 144 (04)
  • [44] USE OF INHALED CORTICOSTEROIDS OR LONG-ACTING β2-AGONISTS AND THE RISK OF PRETERM BIRTH AND LOW-BIRTH WEIGHT AMONG WOMEN WITH ASTHMA
    Cossette, B.
    Forget, A.
    Beauchesne, M. F.
    Lemiere, C.
    Larrivee, P.
    Blais, L.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 173 : S211 - S211
  • [45] The efficacy and safety of different long-acting?2-agonists combined with inhaled glucocorticoid regimens in patients with asthma: a network meta-analysis
    Tang, Ying
    Zhang, Caiyun
    Zhang, Zhigang
    Tian, Jinhui
    JOURNAL OF ASTHMA, 2019, 56 (11) : 1159 - 1171
  • [46] Treatment with inhaled β2-agonists or oral leukotriene antagonist do not enhance physical performance in nonasthmatic highly trained athletes exposed to-15°C
    Sandsund, M
    Sue-Chu, M
    Reinertsen, RE
    Helgerud, J
    Holand, B
    Bjermer, L
    JOURNAL OF THERMAL BIOLOGY, 2000, 25 (1-2) : 181 - 185
  • [47] Imorovina asthma control in patients suboptimally controlled on inhaled steroids and longacting β2-agonists:: addition of montelukast in an open-label pilot study
    Dupont, L
    Potvin, E
    Korn, D
    Lachman, A
    Dramaix, M
    Gusman, J
    Peché, R
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (06) : 863 - 869
  • [48] Systemic activity of two different dry powder combinations of inhaled corticosteroids and long-acting β2-agonists in children with asthma assessed by knemometry
    Wolthers, Ole D.
    Shah, Tushar
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [49] The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis
    Ian D. Pavord
    Nicola Mathieson
    Anna Scowcroft
    Riccardo Pedersini
    Gina Isherwood
    David Price
    npj Primary Care Respiratory Medicine, 27
  • [50] The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis
    Pavord, Ian D.
    Mathieson, Nicola
    Scowcroft, Anna
    Pedersini, Riccardo
    Isherwood, Gina
    Price, David
    NPJ PRIMARY CARE RESPIRATORY MEDICINE, 2017, 27